III.L 0MSFT 0.31GO.U.TO 0.3CIU.PR.A.TO 0DAL -0.02CDZ.TO 0.42NET -0.42KLAC 1.81
Daily Stock Opinions and Ratings
Stockchase Opinions

Mike S. Newton, CIM FCSILife Technologies CorporationLIFEPAST TOP PICKSep 27, 2010

(A Top Pick Oct 27/09. Up 0.83%.) Got stopped out. Still a good buy.
Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
No
Unlock Rating
$47.62

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

Life Technologies Corporation(LIFE)

Oct 16, 2012

(Top Pick Sep 13/11, Up 26.05%) Continues to do well. Still loves it.

Photo of Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
Owned
Unlock Rating
$49.77

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Life Technologies Corporation(LIFE)

Aug 14, 2012

(A Top Pick Sept 13/11. Up 19.62%.) Biotechnology, biopharmaceutical. Currently they are doing a DNA sequencing kit that is under $1000 and takes 2 weeks. Has considerable cash flow and great metrics. Wouldn’t be surprised if it got taken out by a private equity firm.

Photo of Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
Owned
Unlock Rating
$46.69

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Life Technologies Corporation(LIFE)

Apr 03, 2012
(A Top Pick Sept 13/11. Up 23.96%.) Came out in January with a very cheap product that does DNA sequencing. Continues to be a name that is suggested as a takeout candidate.
Photo of Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
Owned
Unlock Rating
$48.68

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Life Technologies Corporation(LIFE)

Sep 13, 2011
Owned in the past and it did him very well. One of the best and largest life sciences in the S&P 500. Once of the best assets in that space. A similar company was bought for a 40% premium. Government safety program, diagnostic equipment.
Photo of Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
Owned
Unlock Rating
$39.15

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Life Technologies Corporation(LIFE)

Oct 27, 2009
Trades at only 10 times earnings. Largest life sciences in S&P 500. Nice looking chart. In 90% of all lab work, from forensic to agricultural. High growth profile that is just starting to take off. Excellent earnings.
Photo of Mike S. Newton, CIM FCSIMike S. Newton, CIM FCSI
Owned
Unlock Rating
$46.61

Stock price when the opinion was issued

$19.55

As of Jul 02, 2026. Market Open.

biotechnologypharmaceutical

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

NFLX 0$77.65
GOOG -0.5$355.68
CAT 1.47$965
NFLX 0$77.65
AAPL -0.2$308.43
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

III.L 0$2999
MSFT 0.31$390.8
GO.U.TO 0.3$9.55
CIU.PR.A… 0$
DAL -0.02$92.73

Popular Articles

Latest Sell Signals

CAT 1.47$965
ASML 5.87$1775.1899
TRI.TO -1.74$124.88
EIF.TO 2.09$132.94
MU 0.84$976.4

Most Recent Experts

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Kevin Simpson

Kevin Simpson

Capital Wealth Planning

Josh Brown, CEO, Ritholtz Wealth Management

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Michael Hakes - CFA, MBA

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephanie Link, Chief investment strategist, Hightower

Stephanie Link, Chief investment strategist, Hightower

Hightower

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica